These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


353 related items for PubMed ID: 22001531

  • 1. Nanohybrid systems of non-ionic surfactant inserting liposomes loading paclitaxel for reversal of multidrug resistance.
    Ji X, Gao Y, Chen L, Zhang Z, Deng Y, Li Y.
    Int J Pharm; 2012 Jan 17; 422(1-2):390-7. PubMed ID: 22001531
    [Abstract] [Full Text] [Related]

  • 2. Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux.
    Chavanpatil MD, Patil Y, Panyam J.
    Int J Pharm; 2006 Aug 31; 320(1-2):150-6. PubMed ID: 16713148
    [Abstract] [Full Text] [Related]

  • 3. 2-Hydroxypropyl-β-cyclodextrin-modified SLN of paclitaxel for overcoming p-glycoprotein function in multidrug-resistant breast cancer cells.
    Baek JS, Cho CW.
    J Pharm Pharmacol; 2013 Jan 31; 65(1):72-8. PubMed ID: 23215690
    [Abstract] [Full Text] [Related]

  • 4. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH.
    Life Sci; 2008 Nov 21; 83(21-22):700-8. PubMed ID: 18845169
    [Abstract] [Full Text] [Related]

  • 5. Long-circulating PEG-PE micelles co-loaded with paclitaxel and elacridar (GG918) overcome multidrug resistance.
    Sarisozen C, Vural I, Levchenko T, Hincal AA, Torchilin VP.
    Drug Deliv; 2012 Nov 21; 19(8):363-70. PubMed ID: 23030458
    [Abstract] [Full Text] [Related]

  • 6. Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel -polymer micelles to overcome multi-drug resistance.
    Wang F, Zhang D, Zhang Q, Chen Y, Zheng D, Hao L, Duan C, Jia L, Liu G, Liu Y.
    Biomaterials; 2011 Dec 21; 32(35):9444-56. PubMed ID: 21903258
    [Abstract] [Full Text] [Related]

  • 7. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
    Wang S, Chen T, Chen R, Hu Y, Chen M, Wang Y.
    Int J Pharm; 2012 Jul 01; 430(1-2):238-46. PubMed ID: 22465546
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Enhanced in vitro cellular uptake of P-gp substrate by poloxamer-modified liposomes (PMLs) in MDR cancer cells.
    Song CK, Balakrishnan P, Shim CK, Chung SJ, Kim DD.
    J Microencapsul; 2011 Jul 01; 28(6):575-81. PubMed ID: 21770706
    [Abstract] [Full Text] [Related]

  • 12. [Preparation, characterization of paclitaxel-loaded Pluronic P105 polymeric micelles and in vitro reversal of multidrug resistant tumor].
    Wang YZ, Fang XL, Li YJ, Zhang ZW, Han LM, Sha XY.
    Yao Xue Xue Bao; 2008 Jun 01; 43(6):640-6. PubMed ID: 18822969
    [Abstract] [Full Text] [Related]

  • 13. In vitro cytotoxic activity of cationic paclitaxel nanoparticles on MDR-3T3 cells.
    Niu G, Castro CH, Nguyen N, Sullivan SM, Hughes JA.
    J Drug Target; 2010 Jul 01; 18(6):468-76. PubMed ID: 20059301
    [Abstract] [Full Text] [Related]

  • 14. A novel approach to overcome multidrug resistance: utilization of P-gp mediated efflux of paclitaxel to attack neighboring vascular endothelial cells in tumors.
    Yoshizawa Y, Ogawara K, Kimura T, Higaki K.
    Eur J Pharm Sci; 2014 Oct 01; 62():274-80. PubMed ID: 24956463
    [Abstract] [Full Text] [Related]

  • 15. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX, Yang XH.
    Yao Xue Xue Bao; 2008 May 01; 43(5):461-6. PubMed ID: 18717331
    [Abstract] [Full Text] [Related]

  • 16. PEG-PE-based micelles co-loaded with paclitaxel and cyclosporine A or loaded with paclitaxel and targeted by anticancer antibody overcome drug resistance in cancer cells.
    Sarisozen C, Vural I, Levchenko T, Hincal AA, Torchilin VP.
    Drug Deliv; 2012 May 01; 19(4):169-76. PubMed ID: 22506922
    [Abstract] [Full Text] [Related]

  • 17. Anti-proliferative activity and suppression of P-glycoprotein by (-)-antofine, a natural phenanthroindolizidine alkaloid, in paclitaxel-resistant human lung cancer cells.
    Kim EH, Min HY, Chung HJ, Song J, Park HJ, Kim S, Lee SK.
    Food Chem Toxicol; 2012 Mar 01; 50(3-4):1060-5. PubMed ID: 22120505
    [Abstract] [Full Text] [Related]

  • 18. Role of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micelles.
    Xiao L, Xiong X, Sun X, Zhu Y, Yang H, Chen H, Gan L, Xu H, Yang X.
    Biomaterials; 2011 Aug 01; 32(22):5148-57. PubMed ID: 21546083
    [Abstract] [Full Text] [Related]

  • 19. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL, Onda K, Tanaka S, Toma T, Hirano T, Oka K.
    Cancer Chemother Pharmacol; 2002 May 01; 49(5):391-7. PubMed ID: 11976833
    [Abstract] [Full Text] [Related]

  • 20. Impact of intraperitoneal, sustained delivery of paclitaxel on the expression of P-glycoprotein in ovarian tumors.
    Ho EA, Soo PL, Allen C, Piquette-Miller M.
    J Control Release; 2007 Jan 22; 117(1):20-7. PubMed ID: 17113177
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.